Case of thrombotic thrombocytopenic purpura associated with disseminated gastric cancer [1]

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 6, 2002, Pages 632-

  Alexopoulou, Alexandra ^a   Dourakis, Spyros P ^a   Nomikou, Efrossini ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL;

AGED; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; GERIATRIC PATIENT; HUMAN; LETTER; MALE; PLASMAPHERESIS; PROGNOSIS; STOMACH CANCER; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

EID: 0036900869     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200212000-00022     Document Type: Letter

References (5)

1. Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemost 1999;25:217-21.
2. Nordstrom B, Strang P. Microangiopathic hemolytic anemia (MAHA) in cancer. A case report and review. Anticancer Res 1993;13:1845-9.
3. Rosen PJ. Bleeding problems in cancer patient. Hematol Oncol Clin North Am 1992;6:1315-28.
4. Sheldon R, Slaughter D. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer 1986;58:1428-36.
5. Antman KH, Skarin AT, Mayer RJ, et al. Microangiopathic hemolytic anemia and cancer: A review. Medicine 1979;58:377-84.